Zhili Liu

Zhili Liu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in World Neurosurgery
Verified
Journal Article
Closed access
JLJia-Ming Liu
Jia-Ming Liu
XLXin-Hua Long
Xin-Hua Long
YZYang Zhou
Yang Zhou
HPHong-Wei Peng
Hong-Wei Peng
ZLZhili Liu
Zhili Liu
SHShan-Hu Huang
Shan-Hu Huang

1 July 2015 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
JLJiaming Liu
Jiaming Liu
HDHuilin Deng
Huilin Deng
XLXinhua Long
Xinhua Long
XCXuanyin Chen
Xuanyin Chen
RXRisheng Xu
Risheng Xu
ZLZhili Liu
Zhili Liu

12 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WCWen-Zhao Chen
Wen-Zhao Chen
JSJun-Feng Shen
Jun-Feng Shen
YZYang Zhou
Yang Zhou
XCXuan-Yin Chen
Xuan-Yin Chen
JLJiaming Liu
Jiaming Liu
ZLZhili Liu
Zhili Liu
The risk factors for predicting bone metastases in patients with breast cancer are still controversial. Here, a total of 2133 patients with breast cancer, including 327 with bone metastases (15.33%) and 1806 without bone metastases (84.67%) were retrospective reviewed from January 2005 to December 2015. The spine was found to be the most common site for bone metastases, followed by ribs (57.5%), pelvis (54.1%) and sternum (44.3%). The results indicated that axillary lymph node metastases and the concentrations of CA125, CA153, ALP and hemoglobin were the independent risk factors for bone metastases in patients with breast cancer. The receiver operating characteristics (ROC) curves showed that combined axillary lymph node metastases, high CA153 and ALP, with low hemoglobin were the most accurate biomarkers for predicting bone metastases in breast cancer [area under the curve = 0.900], and the sensitivity and specificity for the prediction were 78.5% and 87.8%, respectively. Therefore, breast cancer patients with more axillary lymph node metastases, high serum concentrations of CA125, CA153, ALP and low level of hemoglobin were closely related to bone metastases. Combined axillary lymph node metastases, CA153, ALP with hemoglobin have the highest predictive accuracy for bone metastases in breast cancer.

21 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YZYang Zhou
Yang Zhou
QYQing-Fu Yu
Qing-Fu Yu
APAi-Fen Peng
Ai-Fen Peng
WTWei-Lai Tong
Wei-Lai Tong
JLJiaming Liu
Jiaming Liu
ZLZhili Liu
Zhili Liu
The risk factors of bone metastasis in patients with lung cancer are still unclear. Here, a retrospective study including a series of consecutive patients who were diagnosed with lung cancer between January 2005 and November 2016 was carried out. A total of 2021 patients with lung cancer were included in this study and 23.9% of them were found to be bone metastases. For patients with bone metastases, adenocarcinoma (62.1%) was the most common pathological subtype, and rib (62.3%) was the most frequent distant metastatic site, followed by thoracic (53.8%) and lumbar spine (40.4%). The histopathologic type, CA-125 level and the concentration of alkaline phosphatase (ALP) were identified as the independent risk factors for bone metastases in lung cancer (P = 0.002, P = 0.001 and P < 0.001). The sensitivities and specificities of diagnosing bone metastasis by CA-125 were 32.1% and 80.8%, and by ALP were 41.3% and 77.1%, respectively. Thus, the incidence of bone metastases in lung cancer patients was relative high, and physicians should pay attention to the histopathologic type, the serum CA-125 and ALP concentrations when patients were firstly diagnosed with lung cancer for early detecting bone metastases.

1 June 2016 in World Neurosurgery
Verified
Journal Article
Closed access
JLJia-Ming Liu
Jia-Ming Liu
WCWen-Zhao Chen
Wen-Zhao Chen
BFBi-Qi Fu
Bi-Qi Fu
JCJiang-Wei Chen
Jiang-Wei Chen
ZLZhili Liu
Zhili Liu
SHShan-Hu Huang
Shan-Hu Huang

7 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJia-Ming Liu
Jia-Ming Liu
WTWei-Lai Tong
Wei-Lai Tong
XCXuan-Yin Chen
Xuan-Yin Chen
YZYang Zhou
Yang Zhou
WCWen-Zhao Chen
Wen-Zhao Chen
ZLZhili Liu
Zhili Liu
Dysphagia is a common complication following anterior cervical spine surgery (ACSS). The incidences of dysphagia were variable and controversial. The purpose of this study was to determine the incidence of early dysphagia after ACSS with a new scoring system, and to identify the risk factors of it. A prospective study was carried out and patients who underwent ACSS from March 2014 to August 2014 in our hospital were included in this study. A self-designed dysphagia questionnaire was delivered to all of the patients from the first day to the fifth day after ACSS. Perioperative characteristics of patients were recorded, and incidences and risk factors of dysphagia were analyzed. A total of 104 patients who underwent ACSS were included and incidences of dysphagia from the first to the fifth day after ACSS was 87.5%, 79.81%, 62.14%, 50% and 44.23%, respectively. There was a good correlation between the new dysphagia scoring system and Bazaz scoring system (P < 0.001). Operative time and body mass index (BMI) were the risk factors for dysphagia during the first to the second day postoperatively. However, the dC2-C7angle was the main risk factor for dysphagia from the third to the fifth day after surgery. There were comparatively high incidences of early dysphagia after ACSS, which may be ascribed to operative time, BMI and the dC2-C7 angle.